Aghayeva Afag, Baca Bilgi, Atasoy Deniz, Ferahman Sina, Uludağ Sezgin, Bilgin İsmail Ahmet, Beyatlı Sonay, Mihmanlı İsmail, Hamzaoğlu İsmail
Department of General Surgery, Acıbadem University School of Medicine Atakent Hospital, İstanbul, Turkey.
Department of General Surgery, İstanbul University Cerrahpaşa School of Medicine, İstanbul, Turkey.
Turk J Surg. 2018 Dec 1;34(4):327-330. doi: 10.5152/turkjsurg.2017.3507.
The most serious complication after major liver resection is liver failure. Depending on preoperative liver function, a future liver remnant of 25%-40% is considered sufficient to avoid postoperative liver failure. A new technique known as portal vein ligation combined with in situ splitting has been developed to obtain rapid liver hypertrophy. Herein, we present a case where we performed portal vein ligation combined with in situ splitting. A 37-year-old male patient with a diagnosis of sigmoid adenocarcinoma and liver metastasis underwent anterior resection because of an obstructing sigmoid tumor and received palliative chemotherapy. After chemotherapy, abdominal computed tomography revealed a lesion, 50 mm in diameter, localized between segments 5-8 of the liver on the bifurcation of the anteroposterior segmental branch of the right portal vein. Computed tomography volumetric assessments of the liver were performed in the preoperative period, and it was found that the remnant left liver volume was less than 25%. In the first stage, portal vein ligation and in situ splitting of the liver parenchyma were performed. On the second and sixth postoperative days, computed tomography revealed hypertrophy of the left liver lobe. On the sixth day, a right hepatectomy was performed. Portal vein ligation combined with in situ splitting has been used by surgeons worldwide to obtain rapid and adequate liver hypertrophy. This new approach yields hope for patients with locally advanced liver tumors and may increase the number of curative resections for primary or metastatic liver tumors.
肝大部切除术后最严重的并发症是肝衰竭。根据术前肝功能情况,一般认为未来肝残余量达到25% - 40%足以避免术后肝衰竭。一种名为门静脉结扎联合原位肝劈离的新技术已被研发出来以实现快速肝肥大。在此,我们报告一例实施门静脉结扎联合原位肝劈离的病例。一名37岁男性患者,诊断为乙状结肠癌伴肝转移,因乙状结肠肿瘤梗阻行前切除术,并接受了姑息化疗。化疗后,腹部计算机断层扫描显示在右门静脉前后段分支分叉处、肝5 - 8段之间有一个直径50毫米的病灶。术前对肝脏进行了计算机断层扫描容积评估,发现残余左肝体积小于25%。在第一阶段,进行了门静脉结扎和肝实质原位劈离。术后第2天和第6天,计算机断层扫描显示左肝叶肥大。在第6天,实施了右肝切除术。门静脉结扎联合原位肝劈离已被全球外科医生用于实现快速且充分的肝肥大。这种新方法为局部晚期肝肿瘤患者带来了希望,并可能增加原发性或转移性肝肿瘤的根治性切除数量。